Resistance to lung cancer targeted therapy can be reversed, study suggests
Tuesday, June 10, 2014 - 16:21
in Health & Medicine
Up to 40 percent of lung cancer patients do not respond to a targeted therapy designed to block tumor growth -- a puzzling clinical setback that researchers have long tried to solve. Now, scientists have discovered why that intrinsic resistance occurs -- and they pinpoint a drug they say could potentially reverse it.